🟢 SoftOx Solutions is trading 5.7% up

SoftOx Solutions is trading 5.65% up at NOK 0.13, with no confirmed explanation for the move.

• The latest reported session closed September 29. That day, SoftOx announced Dr. Bruce Montgomery would lead its Clinical Advisory Board and advise on development planning for an anticipated Phase 2b study.
• No September 30 announcement or explicit explanation for the move was found. The broader U.S. market context is modestly positive, but no direct link to this Oslo-listed stock is established.